David White
About David White
David White (age 72) is an independent director of Better Choice Company (now SRx Health Solutions, Inc.) appointed at closing of the SRx transaction on April 24, 2025; he serves as Audit Committee Chair and meets NYSE American independence standards . A seasoned governance and labor executive, White is former National Executive Director and Chief Negotiator of SAG‑AFTRA and a Rhodes Scholar; he holds degrees from Stanford Law School, Oxford University, and Grinnell College . He previously served on the board of Resources Connection, Inc. (RGP) and the Federal Reserve Bank of San Francisco (Audit & Risk Management; Bank Governance committees) .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| SAG‑AFTRA | National Executive Director & Chief Negotiator | 2009–Jun 2021 | Led landmark merger with AFTRA; stabilized and modernized union operations . |
| Resources Connection, Inc. (RGP) | Director; later Lead Independent Director | Jul 2021–Aug 3, 2025 | Corporate Governance & Nominating Committee; resigned to become NFLPA interim executive director . |
| Federal Reserve Bank of San Francisco | Board Member | Not disclosed | Audit & Risk Management Committee; Bank Governance Committee . |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| 3CG Ventures, LLC | CEO | Current | Executive coaching and strategic consulting . |
| NFL Players Association | Interim Executive Director | Aug 2025– | Elected by player reps; leadership of union operations . |
| Ulu Ventures | Strategic Advisor | Current | Venture advisory role . |
Board Governance
- Board composition and appointment: At transaction close (Apr 24, 2025), the board was reconstituted to five members; SRx nominated Adesh Vora (Chair) and David White (independent), Better Choice nominated Michael Young (independent) and Simon Conway, and a mutually selected independent (Lionel Conacher) .
- Independence: White meets NYSE American Rule 803 independence standards .
- Committee assignment: Audit Committee Chair (director-level role as disclosed in proxy supplement) .
- Governance context: Company name changed to SRx Health Solutions, Inc. at closing; legacy BTTR directors resigned except Young and Conacher who appointed three new directors including White .
- Attendance: No post‑closing 2025 attendance rates disclosed to date; prior 2023 board attendance was 100% for then‑serving directors (pre‑transaction) .
Other Directorships & Interlocks
| Company | Sector | Role | Overlap/Conflict Considerations |
|---|---|---|---|
| Resources Connection, Inc. (Nasdaq: RGP) | Professional services | Director; later Lead Independent Director; resigned Aug 3, 2025 | Minimal direct product/market overlap with SRx/BTTR; governance and compensation oversight experience transferable . |
| Federal Reserve Bank of San Francisco | Financial system oversight | Board Member | Regulatory, audit and risk governance expertise; no commercial conflict . |
Expertise & Qualifications
- Audit and risk governance: Board committees at FRBSF and audit chair experience at SRx/BTTR; strong fit for financial oversight during post‑merger integration .
- Complex negotiations and labor leadership: SAG‑AFTRA executive tenure; led merger and modernization initiatives .
- Education and credentials: Rhodes Scholar; Stanford Law School; Oxford University; Grinnell College; broad governance credentials .
Equity Ownership
| Holder | Shares Beneficially Owned | Ownership % | Notes |
|---|---|---|---|
| David White | 140,667 | <0.5% | As disclosed in proxy supplement; Audit Committee Chair; independent . |
- Pledging/hedging: No pledging or hedging of company stock disclosed for White in available proxy materials .
- Ownership guidelines: No director stock ownership guideline compliance disclosures specific to White found in current filings; the 2019 Incentive Plan covers director eligibility but not individual guideline status .
Governance Assessment
- Strengths for investor confidence:
- Independent director with clear audit chair role; governance and risk oversight experience suited to integration and financial controls post‑transaction .
- Deep negotiation and organizational leadership background (SAG‑AFTRA), plus board experience at RGP and FRBSF, enhancing board effectiveness across compliance and strategic oversight .
- Risk indicators and potential RED FLAGS:
- Board reconstitution and change‑of‑control: SRx shareholders own ~87% of the combined company; White was nominated by SRx, which can raise alignment questions despite independence classification .
- Limited disclosed personal ownership (<0.5%) may temper direct alignment with minority shareholders, though committee leadership provides accountability .
- Governance transition risk: Multiple officer/director changes at closing increase reliance on audit and governance processes to maintain control environment quality .
Note: Better Choice Company completed the SRx transaction and changed its corporate name to SRx Health Solutions, Inc. on April 24, 2025; board and committee disclosures post‑closing reference SRx Health Solutions, Inc. (formerly BTTR) .